Dr. Kathleen Ann Salathiel, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 6650 Highland Rd, Waterford, MI 48327 Phone: 248-886-0110 Fax: 248-866-0194 |
Oakland Audiology Audiologist Medicare: Not Enrolled in Medicare Practice Location: 5390 Highland Rd Ste 1, Waterford, MI 48327 Phone: 248-673-8000 Fax: 248-673-0346 |
Sarah R Brown, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 5390 Highland Rd # 1, Waterford, MI 48327 Phone: 248-673-8000 |
Rosalind Leiser, M.A. CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 4202 Pontiac Lk Rd, Waterford, MI 48328 Phone: 248-673-8000 Fax: 248-673-0346 |
Kristen Marie Huizdos, AU.D.,CCC-A Audiologist Medicare: Medicare Enrolled Practice Location: 6650 Highland Rd, Suite 110, Waterford, MI 48327 Phone: 248-886-0110 Fax: 248-886-0194 |
Alliance Hearing Care Audiologist Medicare: Not Enrolled in Medicare Practice Location: 6650 Highland Road, Suite 110, Waterford, MI 48327 Phone: 248-886-0110 Fax: 248-886-0194 |
Ent Care Of Michigan Plc Audiologist Medicare: Not Enrolled in Medicare Practice Location: 5220 Highland Rd Ste 230, Waterford, MI 48327 Phone: 248-254-8900 Fax: 248-599-7191 |
Ms. Wendy C Switalski, MA Audiologist Medicare: Not Enrolled in Medicare Practice Location: 6650 Highland Road, Suite 110, Waterford, MI 48327 Phone: 248-886-0110 |
News Archive
Renal cell carcinoma is the most common type of kidney cancer, and African-Americans and males appear most at risk for this disease that can be asymptomatic until it has spread and become highly lethal, said Dr. Vinata B. Lokeshwar, cancer researcher and chair of the Department of Biochemistry and Molecular Biology at the Medical College of Georgia at Augusta University.
Precision Therapeutics will proudly continue its dedicated support to the NOCC Pittsburgh Chapter's 13th Annual Walk to Break the Silence on Ovarian Cancer. Precision has been a strong supporter of the NOCC 5 Mile Run/5 Mile & 1 Mile walk for over five years, and once again expects a great number of its employees will join together in full force to walk alongside ovarian cancer patients and survivors to help strengthen the partnerships it has forged by supporting the very cancer patients that it strives to help.
A first-of-its-kind study discovered that women and minorities who underwent a percutaneous coronary intervention (PCI) are at a greater risk of experiencing recurrent cardiac events within the first year after their procedure compared to Caucasian men.
Viamet Pharmaceuticals, Inc. announced today that it has entered into a licensing option agreement with the Novartis Option Fund. Under terms of the agreement, Viamet will utilize its proprietary Metallophileâ„¢ Technology to discover and develop novel metalloenzyme inhibitors against a specific metalloenzyme of high interest to Novartis. The agreement includes an upfront fee and potential milestones totaling over $200 million as well as product royalties.
› Verified 9 days ago